EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Short report: Targeted analysis of whole exome sequencing data in Indian cryptogenic stroke patients

Priya Dev, Jenefer M Blackwell iD, Rajiv Kumar, Vijay Mishra, Abhishek Pathak

PLOS One · 2026

DOI: 10.1371/journal.pone.0326554 ↗

Kurz gefasst

Fachartikel in der Zeitschrift PLOS One, 2026. Verfasst von Priya Dev und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurology, Institute of Medical Sciences, Banaras Hindu University, Varanasi, India. Hauptthemen laut MEDLINE: Ischemic Stroke, South Asian People, Exome Sequencing. Die Arbeit nennt 13 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Banaras Hindu University.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Cryptogenic stroke (CS) is an ischemic stroke of unknown cause with increasing incidence in India. Common and rare genetic variants have been associated with the risk of stroke. We carried out targeted analysis of whole exome sequencing on a small cohort of 16 CS patients compared to 16 healthy unaffected relatives to determine whether rare coding variants in genes previously associated with stroke could play a role in India. Variants were filtered for coverage (≥20x) and minor allele frequency (≤0.01). Putative deleterious variants were identified using a range of bioinformatic tools. Targeted analysis was performed by filtering for those variants present in a panel of 220 stroke-related genes. Phenotypes, pathways and cell compartments to which genes carrying putative deleterious (PHRED-scaled CADD scores ≥15) variants belonged were determined using Enrichr. STRING was employed to identify interacting proteins. We identified 17 potentially damaging variants specific to Indian CS patients in 15 genes contributing to phenotypes (e.g., hemorrhage; abnormal blood coagulation; dilated aorta, increased heart weight) and pathways (e.g., platelet degranulation, common pathway of fibrin clot formation; response to elevated platelet cytosolic Ca 2+ ) that were not observed in unaffected relatives. STRING analysis identified 6 genes ( ITGA2B , F13A1 , F5, ATP7A, GLA, ABCC6 ) encoding interacting proteins that could be prioritised for follow-up studies. This should include secondary sequence validation, as well as extended pedigree and functional laboratory-based gene-editing studies to validate the clinical relevance of specific variants to CS. Although limited by small sample size, our study provides novel data on CS in a geographical region and ethnic group not well studied to date.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Ischemic StrokeSouth Asian PeopleExome SequencingHumansIndiaPedigreeIncidenceGenetic VariationGene FrequencyPhenotypeGenetic Predisposition to DiseaseMaleFemaleMiddle AgedAged

Autor:innen und Institutionen

  • Department of Neurology, Institute of Medical Sciences, Banaras Hindu University, Varanasi, India.
  • The Kids Research Institute Australia, University of Western Australia, Perth, Western Australia, Australia.
  • Centre of Experimental Medicine & Surgery, Institute of Medical Sciences, Banaras Hindu University, Varanasi, India.

ORCID-Profile: Jenefer M Blackwell

Förderung

  • Banaras Hindu University

Zitieren

APA

Dev, P., Blackwell, J. M., Kumar, R., Mishra, V., & Pathak, A. (2026). Short report: Targeted analysis of whole exome sequencing data in Indian cryptogenic stroke patients. PLOS One. https://doi.org/10.1371/journal.pone.0326554

Vancouver

Dev P, Blackwell JM, Kumar R, Mishra V, Pathak A. Short report: Targeted analysis of whole exome sequencing data in Indian cryptogenic stroke patients. PLOS One. 2026. doi:10.1371/journal.pone.0326554

BibTeX
@article{Dev2026,
  author = {Dev, Priya and Blackwell, Jenefer M and Kumar, Rajiv and Mishra, Vijay and Pathak, Abhishek},
  title = {Short report: Targeted analysis of whole exome sequencing data in Indian cryptogenic stroke patients},
  journal = {PLOS One},
  year = {2026},
  doi = {10.1371/journal.pone.0326554}
}
Kostenlos starten →